Autopsy report · NCT00857233
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Cause of deathNo reason given
“Please see explanation in the Detailed Description field.”
Life of this trial
- Registered 4 years 9 months after it had already started.
- Ran for about 6 years 4 months before it stopped.
- 297 participants enrolled.
- Results were posted on the registry 1 year 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- H. Lundbeck A/S
- Sponsor type
- Industry
- Conditions
- Alzheimer's Disease
- Interventions
- Memantine
- Participants
- 297
- Sites
- 33
- Countries
- Canada
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.